Galvin-McLaughlin Deirdre, Klee Daniel, Memmott Tab, Peters Betts, Wiedrick Jack, Fried-Oken Melanie, Oken Barry
Institute on Development & Disability, Department of Pediatrics, Oregon Health & Science University, Portland, OR, USA.
Department of Neurology, Oregon Health & Science University, Portland, OR, USA.
Contemp Clin Trials Commun. 2022 Jun 13;28:100950. doi: 10.1016/j.conctc.2022.100950. eCollection 2022 Aug.
Brain-computer interface (BCI) systems are controlled by users through neurophysiological input for a variety of applications, including communication, environmental control, and motor rehabilitation. Although individuals with severe speech and physical impairment are the primary users of this technology, BCIs have emerged as a potential tool for broader populations, including delivering cognitive training/interventions with neurofeedback (NFB).
This paper describes the development and preliminary testing of a protocol for use of a BCI system with NFB as an intervention for people with mild Alzheimer's disease (AD). The intervention focused on training visual attention and language skills, as AD is often associated with functional impairments in both. This funded pilot study called for enrolling five participants with mild AD in a six-week BCI EEG-based NFB intervention that followed a four-to-seven-week baseline phase. While two participants completed the study, the remaining three participants could not complete the intervention phase because of COVID-19 restrictions.
Preliminary pilot results suggested: (1) participants with mild AD were able to participate in a study with multiple assessments per week and complete all outcome measures, (2) most outcome measures were reliable during the baseline phase, and (3) all participants with mild AD learned to operate a BCI spelling system with training.
Although preliminary results demonstrate practical feasibility to deliver NFB intervention using a BCI to adults with AD, completion of the protocol in its entirety with more participants is needed to further assess whether implementing NFB-based cognitive intervention is justified by functional treatment outcomes.
This study was registered with ClinicalTrials.gov (NCT03790774).
脑机接口(BCI)系统由用户通过神经生理输入进行控制,用于多种应用,包括通信、环境控制和运动康复。尽管严重言语和身体障碍的个体是这项技术的主要用户,但BCI已成为更广泛人群的潜在工具,包括提供神经反馈(NFB)的认知训练/干预。
本文描述了一种使用带有NFB的BCI系统作为轻度阿尔茨海默病(AD)患者干预措施的方案的开发和初步测试。该干预措施侧重于训练视觉注意力和语言技能,因为AD通常与这两方面的功能障碍有关。这项有资金支持的试点研究要求招募五名轻度AD患者,进行为期六周的基于BCI脑电图的NFB干预,干预前有四到七周的基线期。虽然两名参与者完成了研究,但由于新冠疫情限制,其余三名参与者未能完成干预阶段。
初步试点结果表明:(1)轻度AD患者能够参与每周进行多次评估的研究并完成所有结果测量,(2)大多数结果测量在基线期是可靠的,(3)所有轻度AD患者通过训练学会了操作BCI拼写系统。
尽管初步结果证明了使用BCI对AD成人患者进行NFB干预的实际可行性,但需要更多参与者完整完成该方案,以进一步评估基于NFB的认知干预是否能通过功能治疗结果得到合理证明。
本研究已在ClinicalTrials.gov(NCT03790774)注册。